These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38411770)
1. Practical methods to differentiate thymic malignancies by positron-emission tomography and tumor markers. Yanagihara T; Kawamura T; Maki N; Kobayashi N; Kikuchi S; Goto Y; Ichimura H; Sato Y Surg Today; 2024 Aug; 54(8):899-906. PubMed ID: 38411770 [TBL] [Abstract][Full Text] [Related]
2. Elevated serum CYFRA 21-1 level as a diagnostic marker for thymic carcinoma. Shiiya H; Ujiie H; Hida Y; Kato T; Kaga K; Wakasa S; Kikuchi E; Shinagawa N; Okada K; Ito YM; Matsuno Y Thorac Cancer; 2021 Nov; 12(21):2933-2942. PubMed ID: 34581013 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography/computed tomography as a clinical diagnostic tool for anterior mediastinal tumors. Watanabe T; Shimomura H; Mutoh T; Saito R; Goto R; Yamada T; Notsuda H; Matsuda Y; Noda M; Sakurada A; Taki Y; Okada Y Surg Today; 2019 Feb; 49(2):143-149. PubMed ID: 30198048 [TBL] [Abstract][Full Text] [Related]
4. Age- and gender-specific disease distribution and the diagnostic accuracy of CT for resected anterior mediastinal lesions. Nam JG; Goo JM; Park CM; Lee HJ; Lee CH; Yoon SH Thorac Cancer; 2019 Jun; 10(6):1378-1387. PubMed ID: 31033234 [TBL] [Abstract][Full Text] [Related]
6. A diagnostic model based on Zhou S; Tsui P; Lin M; Chen G; Chen W; Cai X BMC Med Imaging; 2024 Jan; 24(1):14. PubMed ID: 38191331 [TBL] [Abstract][Full Text] [Related]
7. The Role of [ Civan C; Ozkan ZG; Ozkan B; Isik EG; Erdogdu E; Has Simsek D; Duman S; Sanli Y; Kara M; Kuyumcu S; Toker A Cancer Biother Radiopharm; 2024 Jun; 39(5):373-380. PubMed ID: 38484307 [No Abstract] [Full Text] [Related]
8. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of positron-emission tomography for predicting the World Health Organization grade of thymic epithelial tumors. Kanou T; Funaki S; Minami M; Ose N; Kimura T; Fukui E; Watabe T; Shintani Y Thorac Cancer; 2022 Jun; 13(11):1651-1656. PubMed ID: 35460177 [TBL] [Abstract][Full Text] [Related]
10. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies. Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors. Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H Eur J Cardiothorac Surg; 2011 Jul; 40(1):143-5. PubMed ID: 20951602 [TBL] [Abstract][Full Text] [Related]
12. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120 [TBL] [Abstract][Full Text] [Related]
13. Diffusion Weighted Imaging Can Distinguish Benign from Malignant Mediastinal Tumors and Mass Lesions: Comparison with Positron Emission Tomography. Usuda K; Maeda S; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Watanabe N; Tonami H; Ueda Y; Sagawa M Asian Pac J Cancer Prev; 2015; 16(15):6469-75. PubMed ID: 26434861 [TBL] [Abstract][Full Text] [Related]
14. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867 [TBL] [Abstract][Full Text] [Related]
15. Pitfalls of FNA diagnosis of thymic tumors. Wang M; Kundu U; Gong Y Cancer Cytopathol; 2020 Jan; 128(1):57-67. PubMed ID: 31742902 [TBL] [Abstract][Full Text] [Related]
16. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors. Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic values of 2-[ Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035 [TBL] [Abstract][Full Text] [Related]
18. The role of Tc-99m-2-Methoxy-Isobutyl-Isonitrile Single Photon Emission Computed Tomography in visualizing anterior mediastinal tumor and differentiating histologic type of thymoma. Fiorelli A; Vicidomini G; Laperuta P; Rambaldi P; Mansi L; Rotondo A; Santini M Eur J Cardiothorac Surg; 2011 Jul; 40(1):136-42. PubMed ID: 21273088 [TBL] [Abstract][Full Text] [Related]
19. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors. Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782 [No Abstract] [Full Text] [Related]
20. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis. Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]